| Gabriel S Levi, MD | |
|
1 Diamond Hill Rd Fl G, Berkeley Heights, NJ 07922-2104 | |
| (908) 277-8699 | |
| (908) 673-7388 |
| Full Name | Gabriel S Levi |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 34 Years |
| Location | 1 Diamond Hill Rd Fl G, Berkeley Heights, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205834140 | NPI | - | NPPES |
| A400062328 | Other | NY | NGS |
| 01629372 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai St Luke's Roosevelt Hospital | New york, NY | Hospital |
| Mount Sinai Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Medical Of Upper East Side Pllc | 0648465039 | 759 |
| Gastroenterology And Liver Associates Of Riverdale Pc | 1456529098 | 6 |
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
| Optum Medical Care Pc | 9931013240 | 997 |
| Summit Medical Group Pa | 5395642276 | 1253 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Optum Medical Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982643003 PECOS PAC ID: 9931013240 Enrollment ID: O20031119000321 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Westchester Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881653822 PECOS PAC ID: 6406752963 Enrollment ID: O20031208000533 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Prohealth Care Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275596280 PECOS PAC ID: 4486544186 Enrollment ID: O20040317000468 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Ng Medical Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710176870 PECOS PAC ID: 3971587882 Enrollment ID: O20040617000557 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Manhattan Medical Partners, P.l.l.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750599304 PECOS PAC ID: 3274422548 Enrollment ID: O20040916000873 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | City Medical Of Upper East Side Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801277629 PECOS PAC ID: 0648465039 Enrollment ID: O20101111000052 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Gastroenterology And Liver Associates Of Riverdale Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023272846 PECOS PAC ID: 1456529098 Enrollment ID: O20110726000193 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104162700 PECOS PAC ID: 2264691070 Enrollment ID: O20130601000000 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Cwern-hsu Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437592839 PECOS PAC ID: 8022259142 Enrollment ID: O20130731000815 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Fpa Hospital Based |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629319413 PECOS PAC ID: 4789826694 Enrollment ID: O20130806000185 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Maiden Lane Medical Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497291074 PECOS PAC ID: 2365728698 Enrollment ID: O20170420001654 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Entity Name | Vanguard Gastroenterology Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720639388 PECOS PAC ID: 1052744588 Enrollment ID: O20191213001232 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gabriel S Levi, MD 1 Diamond Hill Rd, Berkeley Heights, NJ 07922-2104 Ph: () - | Gabriel S Levi, MD 1 Diamond Hill Rd Fl G, Berkeley Heights, NJ 07922-2104 Ph: (908) 277-8699 |
News Archive
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
The government of Lesotho has approved a policy to care for orphans and vulnerable children, including those who have lost at least one parent to AIDS-related illnesses, IRIN News reports.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 6 days ago
Nikolay D Dimov, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8699 Fax: 908-673-7388 | |
Mr. Ara Meradian, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8699 Fax: 908-673-7388 | |
Anup Hazra, Pathology Medicare: Medicare Enrolled Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 Fax: 908-277-8756 | |
John Paul Bouffard, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd Fl G, Berkeley Heights, NJ 07922 Phone: 908-277-8699 Fax: 908-673-7388 | |
Fang Qian, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 | |
Rachel C Ochs, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 |